These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7654466)

  • 21. Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism.
    Fleisch H
    Recent Results Cancer Res; 1989; 116():1-28. PubMed ID: 2669065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships of various bisphosphonates.
    Shinoda H; Adamek G; Felix R; Fleisch H; Schenk R; Hagan P
    Calcif Tissue Int; 1983; 35(1):87-99. PubMed ID: 6839194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
    Widler L; Jaeggi KA; Glatt M; Müller K; Bachmann R; Bisping M; Born AR; Cortesi R; Guiglia G; Jeker H; Klein R; Ramseier U; Schmid J; Schreiber G; Seltenmeyer Y; Green JR
    J Med Chem; 2002 Aug; 45(17):3721-38. PubMed ID: 12166945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels?
    Persy V; De Broe M; Ketteler M
    Kidney Int; 2006 Nov; 70(9):1537-8. PubMed ID: 17051257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of bisphosphonates.
    Rogers MJ; Watts DJ; Russell RG
    Cancer; 1997 Oct; 80(8 Suppl):1652-60. PubMed ID: 9362432
    [No Abstract]   [Full Text] [Related]  

  • 26. Bisphosphonate treatment of bone disease.
    Shaw NJ; Bishop NJ
    Arch Dis Child; 2005 May; 90(5):494-9. PubMed ID: 15851432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibitory effects of bisphosphonates on bone resorption].
    Shinoda H
    Nihon Yakurigaku Zasshi; 1995 May; 105(5):285-94. PubMed ID: 7628780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on novel bone resorption inhibitors. I. Synthesis and pharmacological activities of aminomethylenebisphosphonate derivatives.
    Takeuchi M; Sakamoto S; Yoshida M; Abe T; Isomura Y
    Chem Pharm Bull (Tokyo); 1993 Apr; 41(4):688-93. PubMed ID: 8508470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.
    Schenk R; Eggli P; Fleisch H; Rosini S
    Calcif Tissue Int; 1986 Jun; 38(6):342-9. PubMed ID: 3089557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of bone resorption by the bisphosphonate BM 21.0955 is not associated with an alteration of the renal handling of calcium in rats infused with parathyroid hormone-related protein.
    Rizzoli R; Caverzasio J; Bauss F; Bonjour JP
    Bone; 1992; 13(4):321-5. PubMed ID: 1389572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold Dictyostelium discoideum.
    Rogers MJ; Watts DJ; Russell RG; Ji X; Xiong X; Blackburn GM; Bayless AV; Ebetino FH
    J Bone Miner Res; 1994 Jul; 9(7):1029-39. PubMed ID: 7942149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural requirements for bisphosphonate actions in vitro.
    van Beek E; Hoekstra M; van de Ruit M; Löwik C; Papapoulos S
    J Bone Miner Res; 1994 Dec; 9(12):1875-82. PubMed ID: 7872052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae.
    Rogers MJ; Xiong X; Brown RJ; Watts DJ; Russell RG; Bayless AV; Ebetino FH
    Mol Pharmacol; 1995 Feb; 47(2):398-402. PubMed ID: 7870050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between the chemistry and biological activity of the bisphosphonates.
    Ebetino FH; Hogan AM; Sun S; Tsoumpra MK; Duan X; Triffitt JT; Kwaasi AA; Dunford JE; Barnett BL; Oppermann U; Lundy MW; Boyde A; Kashemirov BA; McKenna CE; Russell RG
    Bone; 2011 Jul; 49(1):20-33. PubMed ID: 21497677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel bone-targeted Src tyrosine kinase inhibitor drug discovery.
    Shakespeare WC; Metcalf CA; Wang Y; Sundaramoorthi R; Keenan T; Weigele M; Bohacek RS; Dalgarno DC; Sawyer TK
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):729-41. PubMed ID: 14579523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical bisphosphonate augments fixation of bone-grafted hydroxyapatite coated implants, BMP-2 causes resorption-based decrease in bone.
    Baas J; Vestermark M; Jensen T; Bechtold J; Soballe K; Jakobsen T
    Bone; 2017 Apr; 97():76-82. PubMed ID: 28082076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Progress and problems in oral bisphosphonate].
    Takeuchi Y
    Clin Calcium; 2014 Jan; 24(1):27-33. PubMed ID: 24369277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonates--history and experimental basis.
    Fleisch H
    Bone; 1987; 8 Suppl 1():S23-8. PubMed ID: 3318890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy.
    Murakami H; Nakamura T; Tsurukami H; Abe M; Barbier A; Suzuki K
    J Bone Miner Res; 1994 Sep; 9(9):1355-64. PubMed ID: 7529459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of bisphosphonates on vitamin A-induced bone resorption in thyroparathyroidectomized rat].
    Gen M
    Nihon Seikeigeka Gakkai Zasshi; 1995 Nov; 69(11):1193-207. PubMed ID: 8568374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.